Impaired cellular and humoral immunity is a feature of Diamond-Blackfan anaemia; experience of 107 unselected cases in the United Kingdom

Br J Haematol. 2019 Jul;186(2):321-326. doi: 10.1111/bjh.15915. Epub 2019 Apr 13.

Abstract

Diamond-Blackfan anaemia (DBA) is a rare bone marrow failure syndrome characterised by anaemia, congenital anomalies and cancer predisposition. Although infections are the second leading cause of mortality in non-transplanted patients, immune function is largely unexplored. We identified quantitative deficits in serum immunoglobulins and/or circulating T, natural killer and B lymphocytes in 59 of 107 unselected patients (55·1%) attending our centre over a 7-year period. Immune abnormalities were independent of ribosomal protein genotype and arose in both steroid-treated and steroid-untreated patients. In summary, these data highlight the high prevalence and spectrum of infections and immune defects in DBA.

Keywords: Diamond-Blackfan; bone marrow failure; corticosteroids; immunodeficiency; red blood cell disorders.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Anemia, Diamond-Blackfan* / genetics
  • Anemia, Diamond-Blackfan* / immunology
  • Anemia, Diamond-Blackfan* / mortality
  • Anemia, Diamond-Blackfan* / pathology
  • Child
  • Child, Preschool
  • Female
  • Genotype*
  • Humans
  • Immunity, Cellular*
  • Immunity, Humoral*
  • Infant
  • Male
  • Ribosomal Proteins / genetics
  • Ribosomal Proteins / immunology
  • United Kingdom / epidemiology

Substances

  • Ribosomal Proteins